Factor | Harada2008 (10204)

10.1089/mdr.2008.0836

Use of Methaprim-Sulfonamide Combinations in the Past 6 Months

Swine | None

5

Description

Use of Methaprim-Sulfonamide Combinations in the Past 6 Months

Resistance Outcomes

Resistance Microbe Outcome
Oxytetracycline
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Use of Methaprim-sulfonamides 69.70 33
No Use of Methaprim-sulfonamides 60.40 356
Ampicillin
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Use of Methaprim-sulfonamides 27.30 33
No Use of Methaprim-sulfonamides 21.90 356
Dihydrostreptomycin
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Use of Methaprim-sulfonamides 42.40 33
No Use of Methaprim-sulfonamides 44.10 356
Kanamycin
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Use of Methaprim-sulfonamides 21.20 33
No Use of Methaprim-sulfonamides 14.30 356
Trimethoprim
/
Escherichia coli
See: Table 2 AMR+ (%) AMR- (%) Total (n)
Use of Methaprim-sulfonamides 45.50 33
No Use of Methaprim-sulfonamides 21.60 356